top of page

Programas e serviços do NJCRI

O NJCRI se dedica a oferecer serviços médicos, comportamentais, preventivos e de apoio abrangentes para melhorar a saúde da comunidade. Este é um lugar onde você pode encontrar o apoio necessário para levar uma vida mais saudável.

Como podemos ajudar você

Aconselhamento em Saúde Mental

Nossos serviços de aconselhamento em saúde mental são prestados por profissionais experientes, utilizando práticas baseadas em evidências para promover o bem-estar emocional e a recuperação.

Serviços de Saúde para HIV

O NJCRI oferece serviços abrangentes de saúde para HIV, incluindo testes, tratamento e suporte, com foco na promoção do bem-estar geral e da qualidade de vida.

Grupos de apoio

Facilitamos ambientes de grupo de apoio onde os indivíduos podem se conectar, compartilhar experiências e receber orientação, promovendo um senso de comunidade e compreensão.

Educação e Treinamento

Por meio de programas educacionais e iniciativas de treinamento, capacitamos indivíduos com o conhecimento e as habilidades para tomar decisões informadas sobre sua saúde e bem-estar.

Avaliação e Análise de Dados:

Aconselhamento sobre habitação e emprego

Nossos serviços de aconselhamento abrangem suporte habitacional e de emprego, com o objetivo de proporcionar estabilidade e oportunidades para indivíduos e famílias necessitadas.

Avaliação e Análise de Dados:

Gestão de Casos

O NJCRI oferece defesa e assistência na navegação de programas de benefícios, garantindo que os indivíduos tenham acesso a recursos essenciais para seu bem-estar.

 

2026/2025 Publications and Abstracts 

 

  • Tess Olsson, Corey DeStefano, Paul Buensuceso, MD, Diana Finkel, DO, North Jersey Community Research Initiative (NJCRI), Rutgers University, Gilead Sciences.  Hidden in plain sight: Hepatic steatosis among a sample of clinically engaged transgender and gender diverse people in Newark, NJ, APHA 2026 Annual Meeting and Expo,San Antonio, TX November 1-4, 2026  

  • PAST TREATMENT, PRESENT CURE: COMPARABLE HEPATITIS C OUTCOMES IN A COMMUNITY-BASED PROGRAM, 14th Internation Conference on Health and Hepatitis in Substance Users, INHSU 2026, October 6-9, 2026 Prague, Czech Republic  

  • Slim J1,2,3, Leyden K3, Rosmarin-DeStefano C3, Duprey S3, Martinez D3, Raymond A3, Al-Qerem M2 1 New York Medical College, Valhalla, New York, NY USA 2 St. Michaels Medical Center, Newark, NJ USA 3 North Jersey Community Research Initiative, NJCRI, Newark, NJ USA

  • SUSTAINED VIROLOGIC RESPONSE FOLLOWING SHORT EXPOSURE TO GLECAPREVIR/PIBRENTASVIR: A REAL-WORLD CASE SERIES, 14th Internation Conference on Health and Hepatitis in Substance Users, INHSU 2026, October 6-9, 2026 Prague, Czech Republic 

  • Slim J1,2,3, Leyden K3, Rosmarin-DeStefano C3, Duprey S3, Martinez D3, Raymond A3, Al-Qerem M2 1 New York Medical College, Valhalla, New York, NY USA 2 St. Michaels Medical Center, Newark, NJ USA 3 North Jersey Community Research Initiative, NJCRI, Newark, NJ USA

  • Murad Qirem¹, Alondra Lerebours-Onate¹, Shahd Yaghi¹, Mohammad Abushanab¹, Kevin Leyden², Corey DeStefano², Jihad Slim¹ ¹ New York Medical College, Valhalla, NY² North Jersey Community Research Initiative, Newark, NJ, Clinical and Metabolic Characteristics Associated with Hepatic Steatosis in People Living with HIV and Elevated Body Mass Index, International Association of Provider of AIDS Care, June 22-24, 2026, San Juan, Puerto Rico. 

  • Murad Qirem¹, Alondra Lerebours-Onate¹, Shahd Yaghi¹, Mohammad Abushanab¹, Kevin Leyden², Corey DeStefano², Jihad Slim¹ ¹ New York Medical College, Valhalla, NY² North Jersey Community Research Initiative, Newark, NJ, Predictors of Liver Fibrosis in People Living with HIV, International Association of Provider of AIDS Care, June 22-24, 2026, San Juan, Puerto Rico. 

  • Murad Qirem¹, Alondra Lerebours-Onate¹, Shahd Yaghi¹, Mohammad Abushanab¹, Kevin Leyden², Corey DeStefano², Jihad Slim¹ ¹ New York Medical College, Valhalla, NY² North Jersey Community Research Initiative, Newark, NJ, Visceral Adiposity Index as a Predictor of MASLD in People With HIV:A Multicenter Cross-Sectional Study, International Association of Provider of AIDS Care, June 22-24, 2026, San Juan, Puerto Rico.

  • Murad Qirem¹, Alondra Lerebours-Onate¹, Shahd Yaghi¹, Mohammad Abushanab¹, Kevin Leyden², Corey DeStefano², Jihad Slim¹ ¹ New York Medical College, Valhalla, NY² North Jersey Community Research Initiative, Newark, NJ, Predictors of Hepatic Steatosis in Lean People Living with HIV: A Descriptive Analysis, International Association of Provider of AIDS Care, June 22-24, 2026, San Juan, Puerto Rico.

  • Jihad Slim, Murad Qerem, Shahd, Yaghi, Kevin Leyden, Corey Destefano, Sheena Duprey New York Medical College, Valhalla, NY² North Jersey Community Research Initiative, Newark, NJ, Sustained Virologic Response Rates Following Incomplete Direct-Acting Antiviral Therapy for Hepatitis C: A Real-World Study, EASL Congress 2026 May 27- May 30, 2026 Barcelona, Spain. 

  • Jihad Slim, MD,Barbara Tempalski, PhD, Corey Rosmarin- DeStefano, Kevin Leyden, Emily Levaggi, Sheena Duprey, Juan Torres, Anthony Raymond, Factors Influencing SCR rates in a Mobile Van Care Model of Hepatitis C Treatment, North Jersey Community Research Initiative, Newark, NJ, St Michaels Medical Center, newark, NJ, New York Medical College, Valhalla, NY. World Hepatitis Summit, 2026 4/28/2026-4/30/2026, Bangkok Thailand.

  • Corey Rosmarin- DeStefano, Christian Mendez-Baez, Diana Finkel, DO, Sonia Vera, Angelica Andujar, LPN, Flavia Escalante, Keven Tirado, Karina Landaverde, Maurcio Caro, Tess Olsson, Simmi Dutra. North Jersey Community Research Initiative NJCRI, Rutgers University, Newark, NJ. Enhancing healthcare engagement among transgender and gender diverse people through a community empowerment program, American Public Health Association Conference (APHA), Washington, DC November 2-5, 2025

  • Olsson, Tess, Homelessness and housing insecurity among women of trans experience and transfeminine people in Newark, NJ. American Public Health Association Conference (APHA), Washington, DC November 2-5, 2025

  • Marya Gwadz , Leo Wilton, Charles M. Cleland , Samantha Serrano , Dawa Sherpa , Maria Fernanda Zaldivar , Robin Freeman , Stephanie Campos , Nisha Beharie , Corey Rosmarin-DeStefano , Prema Filippone and Michelle R. Munson, Wilton et al, Social processes and engagement along the HIV care continuum: a mixed methods exploratory study with diverse African American/Black and Latine emerging adults living with HIV. Int J Equity Health 24, 295 (2025). https://doi.org/10.1186/s12939-025-02662-5 (2025)  

  • Slim J, Rosmarin- DeStefano C, Tempalski B, Duprey, S, Leyden, K, Levaggi, E, Torres, J, Raymond, A, Gray, J North Jersey Research Initiative (NJCRI) Low Hepatocellular Carcinoma Surveillance Among Cirrhotic Patients in a Mobile and Telehealth HCV Elimination Program. ID Week, Atlanta, GA October 19-22, 2025. 

  • Slim J, Rosmarin- DeStefano C, Tempalski B, Duprey, S, Leyden, K, Levaggi, E, Torres, J, Raymond, A, Gray, J North Jersey Community Research Initiative (NJCRI) Hepatitis C Patient Characteristics Across Urban, Suburban, Rural Areas: Insights from a New Jersey Mobile Clinic- Based Study, 13th International Conference on Health and Hepatitis in Substance Users Cape Town, South Africa October 14-17, 2025. 

  • Slim J, Rosmarin- DeStefano C, Tempalski B, Duprey, S, Leyden, K, Levaggi, E, Torres, J, Raymond, A, Gray, J North Jersey Community Research Initiative (NJCRI) SVR Rates Among Hepatitis C Clients: Comparing Inpatient and Outpatient in a mobile Clinic in New Jersey, 13th International Conference on Health and Hepatitis in Substance Users, Cape Town, South Africa October 14-17, 2025. 

  • Tess Olsson, North Jersey Community Research Initiative (NJCRI) Stigma, Discrimination, and Health Care Avoidance Among Women of Trans Experience and Transfeminine People in Newark, NJ, GLMA Conference Minneapolis, MN, October 9-11, 2025.

  • Tess Olsson Corey Rosmarin DeStefano, Diana Finkel, DO, Simran Dutta, Flavia Escalante, Freya Diosa- Cox, Imani Hayes For Us with Us: Enhancing PrEP and HIV Care Uptake by Engaging TGD Community in Care by TGD Staff which will be presented at the National Trans Health Summit on 5/31/25 in San Francisco, CA

  • Tess Olsson Corey Rosmarin DeStefano, Diana Finkel, DO, Simran Dutta, Flavia Escalante, Freya Diosa- Cox, Imani Hayes Food Insecurity in Transgender and Gender Diverse Communities: Insights from Newark, NJ which will be presented at the National Trans Health Summit on 5/31/25 in San Francisco, CA

  • A mixed methods descriptive study of a diverse cohort of African American/Black and Latine young and emerging adults living with HIV: Sociodemographic, background, and contextual factors. Marya Gwadz , Leo Wilton, Charles M. Cleland , Samantha Serrano , Dawa Sherpa , Maria Fernanda Zaldivar , Robin Freeman , Stephanie Campos , Nisha Beharie , Corey Rosmarin-DeStefano , Prema Filippone and Michelle R. Munson. Gwadz et al. BMC Public Health (2025) 25:620 https://doi.org/10.1186/s12889-025-21869-3   

  • Tess Olsson Corey Rosmarin DeStefano, Diana Finkel, DO, Simran Dutta, Flavia Escalante, Freya Diosa- Cox, Imani Hayes For Us with Us: Enhancing PrEP and HIV Care Uptake by Engaging TGD Community in Care by TGD Staff which will be presented at the National Trans Health Summit on 5/31/25 in San Francisco, CA

  • Tess Olsson Corey Rosmarin DeStefano, Diana Finkel, DO, Simran Dutta, Flavia Escalante, Freya Diosa- Cox, Imani Hayes Food Insecurity in Transgender and Gender Diverse Communities: Insights from Newark, NJ which will be presented at the National Trans Health Summit on 5/31/25 in San Francisco, CA 

  • A mixed methods descriptive study of a diverse cohort of African American/Black and Latine young and emerging adults living with HIV: Sociodemographic, background, and contextual factors. Marya Gwadz , Leo Wilton, Charles M. Cleland , Samantha Serrano , Dawa Sherpa , Maria Fernanda Zaldivar , Robin Freeman , Stephanie Campos , Nisha Beharie , Corey Rosmarin-DeStefano , Prema Filippone and Michelle R. Munson. Gwadz et al. BMC Public Health (2025) 25:620 https://doi.org/10.1186/s12889-025-21869-3 

2023/2024 Publications and Abstracts 

  • Corey Rosmarin- DeStefano, Jihad Slim, MD, Barbara Tempalski, PhD, Diana Finkel, DO, Kevin Leyden, RN, Emily Levaggi CPT, Juan Torres, CMA, Sheena Duprey, LPN North Jersey Community Research Initiative (NJCRI), Newark, NJ. Understanding Hepatitis C Reinfection and Factors Associated with HCV Infection in New Jersey, USA. Global Hepatitis Summit April 25-28, 2023, Paris France. 

  • Joachim D. Sackey, Mina Ghbrial, Corey Rosmarin-DeStefano, Mishal Khan, Syd Rosen, Juan Torres, Diana Finkel. Food Insecurity, Community Belongingness and Social Support among Adult Transgender Individuals in Newark, New Jersey. American Society for Nutrition, July 22-25, 2023, Boston, MA 

  • Corey Rosmarin- DeStefano, Jihad Slim, MD, Barbara Tempalski, PhD, Kevin Leyden, RN, Emily Levaggi CPT, Juan Torres, CMA, Sheena Duprey, LPN, Evelyn Chavez, Armanious, D, Armanious A, Olsson, T, MPH. North Jersey Community Research Initiative (NJCRI), Newark, NJ. Impact of an Innovative Community Based Contracted Pharmacy on HCV Elimination in New Jersey, ID Week, October 11-14, 2023 Boston, MA. 

  • Corey Rosmarin- DeStefano, Jihad Slim, MD, Barbara Tempalski, PhD, Diana Finkel, DO, Kevin Leyden, RN, Emily Levaggi CPT, Juan Torres, CMA, Sheena Duprey, LPN North Jersey Community Research Initiative (NJCRI), Newark, NJ. Understanding Hepatitis C Reinfection and Factors Associated with HCV Infection in New Jersey, USA. INSHU Conference October 16-20, 2023, Geneva Switzerland. 

  • Corey Rosmarin- DeStefano, Jihad Slim, MD, Barbara Tempalski, PhD, Kevin Leyden, RN, Emily Levaggi CPT, Juan Torres, CMA, Sheena Duprey, LPN, Evelyn Chavez, Armanious, D, Armanious A, Olsson, T, MPH. North Jersey Community Research Initiative (NJCRI), Newark, NJ. Impact of an Innovative Community Based Contracted Pharmacy on HCV Elimination in New Jersey, INSHU Conference October 16-20, 2023, Geneva Switzerland. 

  • Corey Rosmarin- DeStefano, Jihad Slim, MD, Barbara Tempalski, PhD, Kevin Leyden, RN, Emily Levaggi CPT, Juan Torres, CMA, Sheena Duprey, LPN, Evelyn Chavez, Armanious, D, Armanious A, Olsson, T, MPH. North Jersey Community Research Initiative (NJCRI), Newark, NJ. Impact of an Innovative Community Based Contracted Pharmacy on HCV Elimination in New Jersey, American Public Health Association Conference, November 12-15, 2023 Atlanta, GA. 

  • Corey Rosmarin- DeStefano, Jihad Slim, MD, Barbara Tempalski, PhD, Kevin Leyden, RN, Emily Levaggi CPT, Juan Torres CMA, Sheena Duprey, LPN, Evelyn Chavez North Jersey Community Research Initiative (NJCRI), Newark, Pushing back the Fear: An Innovative Mobile Community Based Approach to a Statewide HCV Elimination Initiative in Vulnerable Populations, International Viral Hepatitis Elimination Project (IVHEM 2023) Amsterdam, The Netherlands, December 1-3, 2023. 

  • Corey Rosmarin- DeStefano, Jihad Slim, MD, Barbara Tempalski, PhD, Kevin Leyden, RN, Emily Levaggi CPT, Juan Torres CMA, Sheena Duprey, LPN, Evelyn Chavez North Jersey Community Research Initiative (NJCRI), Newark, NJ Real World Experience with Glecaprevir/Pibrentasvir (G/P) and Sofosbuvir/Velpatasvir (S/V) in New Jersey, USA World Hepatitis Summit Lisbon, Portugal April 9-1, 2024 

  • Christian Mendez Baez, MD, Corey Rosmarin- DeStefano, Kevin Leyden, RN, Diana Finkel, DO, Sonia Vera. Increasing Access to Hepatitis C Care in Latinx Who Inject Drugs. National Latinx Conference on HIV, Hepatitis and STIs San Jose, TX May 2-4, 2024.  

  • Corey Rosmarin DeStefano, Ronald Poblete, MD, Danilo Gamino, Clinical Performance Evaluation of the Polymerase Chain Reaction (PCR)-Based cobas CT/NG/MG Test for Use on the cobas liat System in a Clinical Laboratory Setting and Point-of-Care (POC) Location ADLM Conference July 28 - August 4, 2024, Chicago, Illinois 

  • Corey Rosmarin- DeStefano, Christian Mendez-Baez, Diana Finkel, DO, Marc Picard, MD, Tess Olsson, MPH, Sonia Vera, Angelica Andujar, LPN, Flavia Escalante, Keven Tirado, Karina Landaverde, Maurcio Caro, Gabriel Aquino North Jersey Community Research Initiative NJCRI, Rutgers University, Newark, NJ. Community Based Food Pantry Serves as an Entry Point for HIV Care and Treatment for Migrants in Newark, NJ. National Ryan White Conference on HIV Care and Treatment, Washington, DC August 20-23, 2024. 

  • Slim J, Rosmarin- DeStefano C, Tempalski B, Duprey, S, Leyden, K, Levaggi, E, Torres, J, North Jersey Community Research Initiative (NJCRI) The availability of a portable "fibroscan" in a mobile unit for hepatitis C treatment improves quality of care. International Conference on Health and Hepatitis in Substance Users, Athens Greece, October 8-11, 2024. 

  • Jihad Slim, Maria Akiki, Barbara Tempalski, Corey Rosmarin-DeStefano, Kevin Leyden, Juan Torres, Sheena Duprey, Emily Levaggi, North Jersey Community Research Initiative (NJCRI). Prevalence of Hepatitis B and Hepatitis A in people with chronic active Hepatitis C in NJ. ID Week, Los Angeles, CA October 16-19, 2024. 

  • Corey Rosmarin- DeStefano, Christian Mendez-Baez, Diana Finkel, DO, Marc Picard, MD, Sonia Vera, Angelica Andujar, LPN, Flavia Escalante, Keven Tirado, Karina Landaverde, Maurcio Caro, Gabriel Aquino North Jersey Community Research Initiative NJCRI, Rutgers University, Newark, NJ. Food Pantry in a trusted community Setting serves as an Entry Point for HIV Prevention and Treatment in the Migrant population in Newark, NJ. American Public Health Association (APHA) October 27-30, 2024 Minneapolis, MN. 

  • 2023/2024 Publications and Abstracts 

  • Corey Rosmarin- DeStefano, Jihad Slim, MD, Barbara Tempalski, PhD, Kevin Leyden, RN, Emily Levaggi CPT, Juan Torres, CMA, Sheena Duprey, LPN, Evelyn Chavez, Armanious, D, Armanious A, Olsson, T, MPH. North Jersey Community Research Initiative (NJCRI), Newark, NJ. Impact of an Innovative Community Based Contracted Pharmacy on HCV Elimination in New Jersey, ID Week, October 11-14, 2023 Boston, MA. 

  • Corey Rosmarin- DeStefano, Jihad Slim, MD, Barbara Tempalski, PhD, Diana Finkel, DO, Kevin Leyden, RN, Emily Levaggi CPT, Juan Torres, CMA, Sheena Duprey, LPN North Jersey Community Research Initiative (NJCRI), Newark, NJ. Understanding Hepatitis C Reinfection and Factors Associated with HCV Infection in New Jersey, USA. INSHU Conference October 16-20, 2023, Geneva Switzerland. 

  • Corey Rosmarin- DeStefano, Jihad Slim, MD, Barbara Tempalski, PhD, Kevin Leyden, RN, Emily Levaggi CPT, Juan Torres, CMA, Sheena Duprey, LPN, Evelyn Chavez, Armanious, D, Armanious A, Olsson, T, MPH. North Jersey Community Research Initiative (NJCRI), Newark, NJ. Impact of an Innovative Community Based Contracted Pharmacy on HCV Elimination in New Jersey, INSHU Conference October 16-20, 2023, Geneva Switzerland. 

  • Corey Rosmarin- DeStefano, Jihad Slim, MD, Barbara Tempalski, PhD, Kevin Leyden, RN, Emily Levaggi CPT, Juan Torres, CMA, Sheena Duprey, LPN, Evelyn Chavez, Armanious, D, Armanious A, Olsson, T, MPH. North Jersey Community Research Initiative (NJCRI), Newark, NJ. Impact of an Innovative Community Based Contracted Pharmacy on HCV Elimination in New Jersey, American Public Health Association Conference, November 12-15, 2023 Atlanta, GA. 

  • Corey Rosmarin- DeStefano, Jihad Slim, MD, Barbara Tempalski, PhD, Kevin Leyden, RN, Emily Levaggi CPT, Juan Torres CMA, Sheena Duprey, LPN, Evelyn Chavez North Jersey Community Research Initiative (NJCRI), Newark, Pushing back the Fear: An Innovative Mobile Community Based Approach to a Statewide HCV Elimination Initiative in Vulnerable Populations, International Viral Hepatitis Elimination Project (IVHEM 2023) Amsterdam, The Netherlands, December 1-3, 2023. 

  • Corey Rosmarin- DeStefano, Jihad Slim, MD, Barbara Tempalski, PhD, Kevin Leyden, RN, Emily Levaggi CPT, Juan Torres CMA, Sheena Duprey, LPN, Evelyn Chavez North Jersey Community Research Initiative (NJCRI), Newark, NJ Real World Experience with Glecaprevir/Pibrentasvir (G/P) and Sofosbuvir/Velpatasvir (S/V) in New Jersey, USA World Hepatitis Summit Lisbon, Portugal April 9-1, 2024

  • Christian Mendez Baez, MD, Corey Rosmarin- DeStefano, Kevin Leyden, RN, Diana Finkel, DO, Sonia Vera. Increasing Access to Hepatitis C Care in Latinx Who Inject Drugs. National Latinx Conference on HIV, Hepatitis and STIs San Jose, TX May 2-4, 2024.  

  • Wang P, Wogayehu A, Bolden B, Ibrahim AR, Raymond HF. Assessing Consistency of Respondent-driven Sampling Estimators by Using Repeated Surveys among People Who Inject Drugs (PWID) in New Jersey. AIDS Behav. 2024. Epub. 

  • Corey Rosmarin DeStefano, Ronald Poblete, MD, Danilo Gamino, Clinical Performance Evaluation of the Polymerase Chain Reaction (PCR)-Based cobas CT/NG/MG Test for Use on the cobas liat System in a Clinical Laboratory Setting and Point-of-Care (POC) Location ADLM Conference July 28 - August 4, 2024, Chicago, Illinois 

  • Corey Rosmarin- DeStefano, Christian Mendez-Baez, Diana Finkel, DO, Marc Picard, MD, Tess Olsson, MPH, Sonia Vera, Angelica Andujar, LPN, Flavia Escalante, Keven Tirado, Karina Landaverde, Maurcio Caro, Gabriel Aquino North Jersey Community Research Initiative NJCRI, Rutgers University, Newark, NJ. Community Based Food Pantry Serves as an Entry Point for HIV Care and Treatment for Migrants in Newark, NJ. National Ryan White Conference on HIV Care and Treatment, Washington, DC August 20-23, 2024. 

  • Slim J, Rosmarin- DeStefano C, Tempalski B, Duprey, S, Leyden, K, Levaggi, E, Torres, J, North Jersey Community Research Initiative (NJCRI) The availability of a portable "fibroscan" in a mobile unit for hepatitis C treatment improves quality of care. International Conference on Health and Hepatitis in Substance Users, Athens Greece, October 8-11, 2024. 

  • Jihad Slim, Maria Akiki, Barbara Tempalski, Corey Rosmarin-DeStefano, Kevin Leyden, Juan Torres, Sheena Duprey, Emily Levaggi, North Jersey Community Research Initiative (NJCRI). Prevalence of Hepatitis B and Hepatitis A in people with chronic active Hepatitis C in NJ. ID Week, Los Angeles, CA October 16-19, 2024. 

  • Corey Rosmarin- DeStefano, Christian Mendez-Baez, Diana Finkel, DO, Marc Picard, MD, Sonia Vera, Angelica Andujar, LPN, Flavia Escalante, Keven Tirado, Karina Landaverde, Maurcio Caro, Gabriel Aquino North Jersey Community Research Initiative NJCRI, Rutgers University, Newark, NJ. Food Pantry in a trusted community Setting serves as an Entry Point for HIV Prevention and Treatment in the Migrant population in Newark, NJ. American Public Health Association (APHA) October 27-30, 2024 Minneapolis, MN. 

2023/2024 Publications and Abstracts 

  • Corey Rosmarin- DeStefano, Jihad Slim, MD, Barbara Tempalski, PhD, Kevin Leyden, RN, Emily Levaggi CPT, Juan Torres, CMA, Sheena Duprey, LPN, Evelyn Chavez, Armanious, D, Armanious A, Olsson, T, MPH. North Jersey Community Research Initiative (NJCRI), Newark, NJ. Impact of an Innovative Community Based Contracted Pharmacy on HCV Elimination in New Jersey, ID Week, October 11-14, 2023 Boston, MA. 

  • Corey Rosmarin- DeStefano, Jihad Slim, MD, Barbara Tempalski, PhD, Diana Finkel, DO, Kevin Leyden, RN, Emily Levaggi CPT, Juan Torres, CMA, Sheena Duprey, LPN North Jersey Community Research Initiative (NJCRI), Newark, NJ. Understanding Hepatitis C Reinfection and Factors Associated with HCV Infection in New Jersey, USA. INSHU Conference October 16-20, 2023, Geneva Switzerland. 

  • Corey Rosmarin- DeStefano, Jihad Slim, MD, Barbara Tempalski, PhD, Kevin Leyden, RN, Emily Levaggi CPT, Juan Torres, CMA, Sheena Duprey, LPN, Evelyn Chavez, Armanious, D, Armanious A, Olsson, T, MPH. North Jersey Community Research Initiative (NJCRI), Newark, NJ. Impact of an Innovative Community Based Contracted Pharmacy on HCV Elimination in New Jersey, INSHU Conference October 16-20, 2023, Geneva Switzerland. 

  • Corey Rosmarin- DeStefano, Jihad Slim, MD, Barbara Tempalski, PhD, Kevin Leyden, RN, Emily Levaggi CPT, Juan Torres, CMA, Sheena Duprey, LPN, Evelyn Chavez, Armanious, D, Armanious A, Olsson, T, MPH. North Jersey Community Research Initiative (NJCRI), Newark, NJ. Impact of an Innovative Community Based Contracted Pharmacy on HCV Elimination in New Jersey, American Public Health Association Conference, November 12-15, 2023 Atlanta, GA. 

  • Corey Rosmarin- DeStefano, Jihad Slim, MD, Barbara Tempalski, PhD, Kevin Leyden, RN, Emily Levaggi CPT, Juan Torres CMA, Sheena Duprey, LPN, Evelyn Chavez North Jersey Community Research Initiative (NJCRI), Newark, Pushing back the Fear: An Innovative Mobile Community Based Approach to a Statewide HCV Elimination Initiative in Vulnerable Populations, International Viral Hepatitis Elimination Project (IVHEM 2023) Amsterdam, The Netherlands, December 1-3, 2023. 

  • Corey Rosmarin- DeStefano, Jihad Slim, MD, Barbara Tempalski, PhD, Kevin Leyden, RN, Emily Levaggi CPT, Juan Torres CMA, Sheena Duprey, LPN, Evelyn Chavez North Jersey Community Research Initiative (NJCRI), Newark, NJ Real World Experience with Glecaprevir/Pibrentasvir (G/P) and Sofosbuvir/Velpatasvir (S/V) in New Jersey, USA World Hepatitis Summit Lisbon, Portugal April 9-1, 2024 

  • Christian Mendez Baez, MD, Corey Rosmarin- DeStefano, Kevin Leyden, RN, Diana Finkel, DO, Sonia Vera. Increasing Access to Hepatitis C Care in Latinx Who Inject Drugs. National Latinx Conference on HIV, Hepatitis and STIs San Jose, TX May 2-4, 2024.  

  • Wang P, Wogayehu A, Bolden B, Ibrahim AR, Raymond HF. Assessing Consistency of Respondent-driven Sampling Estimators by Using Repeated Surveys among People Who Inject Drugs (PWID) in New Jersey. AIDS Behav. 2024. Epub. 

  • Corey Rosmarin DeStefano, Ronald Poblete, MD, Danilo Gamino, Clinical Performance Evaluation of the Polymerase Chain Reaction (PCR)-Based cobas CT/NG/MG Test for Use on the cobas liat System in a Clinical Laboratory Setting and Point-of-Care (POC) Location ADLM Conference July 28 - August 4, 2024, Chicago, Illinois 

  • Corey Rosmarin- DeStefano, Christian Mendez-Baez, Diana Finkel, DO, Marc Picard, MD, Tess Olsson, MPH, Sonia Vera, Angelica Andujar, LPN, Flavia Escalante, Keven Tirado, Karina Landaverde, Maurcio Caro, Gabriel Aquino North Jersey Community Research Initiative NJCRI, Rutgers University, Newark, NJ. Community Based Food Pantry Serves as an Entry Point for HIV Care and Treatment for Migrants in Newark, NJ. National Ryan White Conference on HIV Care and Treatment, Washington, DC August 20-23, 2024. 

  • Corey Rosmarin DeStefano, Ronald Poblete, MD, Danilo Gamino, Clinical Performance Evaluation of the Polymerase Chain Reaction (PCR)-Based cobas CT/NG/MG Test for Use on the cobas liat System in a Clinical Laboratory Setting and Point-of-Care (POC) Location ADLM Conference July 28 - August 4, 2024, Chicago, Illinois 

  • Slim J, Rosmarin- DeStefano C, Tempalski B, Duprey, S, Leyden, K, Levaggi, E, Torres, J, North Jersey Community Research Initiative (NJCRI) The availability of a portable "fibroscan" in a mobile unit for hepatitis C treatment improves quality of care. International Conference on Health and Hepatitis in Substance Users, Athens Greece, October 8-11, 2024. 

  • Jihad Slim, Maria Akiki, Barbara Tempalski, Corey Rosmarin-DeStefano, Kevin Leyden, Juan Torres, Sheena Duprey, Emily Levaggi, North Jersey Community Research Initiative (NJCRI). Prevalence of Hepatitis B and Hepatitis A in people with chronic active Hepatitis C in NJ. ID Week, Los Angeles, CA October 16-19, 2024. 

  • Corey Rosmarin- DeStefano, Christian Mendez-Baez, Diana Finkel, DO, Marc Picard, MD, Sonia Vera, Angelica Andujar, LPN, Flavia Escalante, Keven Tirado, Karina Landaverde, Maurcio Caro, Gabriel Aquino North Jersey Community Research Initiative NJCRI, Rutgers University, Newark, NJ. Food Pantry in a trusted community Setting serves as an Entry Point for HIV Prevention and Treatment in the Migrant population in Newark, NJ. American Public Health Association (APHA) October 27-30, 2024 Minneapolis, MN. 

  • Publications 1988-2010 

  • Bishburg, E, Eng RH, Slim, J, Perez G, Johnson, E. Brain lesions in patients with acquired immunodeficiency syndrome.  Arch Int Med 1989; 149: 941-43. 

  • Bogden J.D,  Baker H, Frank O, Perez G, et.al.  Micronutrient status and human immunodeficiency virus (HIV) infection.  Annals New York Academy of Sciences 1990; 597:189-195. 

  • Jacobson M, Besch L, Child C, Hafner R, Matts M, Muth K, Wentworth D, Neaton JD, Abrams DA, Rimland J, Perez G, et al.  Prophylaxis and pyrimethamine for Toxaplasmic encephalitis in patients with advanced HIV disease:  results of a randomized trial. JID 1996;169: 384-394. 

  • Denny T, Skurnick JH, Garcia A, Perez G, et al.  Lymphocyte immunoregulatory cells present in semen from human immunodeficiency (HIV)-infected individuals: a report from the HIV Heterosexual Transmission Study.  Cytometry 1996; 587: 189-95. 

  • Gordin F, Matts J, Miller C, Brown LS, Hafner R, John S, Klein M, Vaughn A, Besch CL; Perez G; Szabo S, El-Sadr W.  A Controlled Trial of Isoniazid in Persons with Anergy and Human Immunodeficiency Virus Infection Who Are at High Risk for Tuberculosis.  N. Engl J. Med 1997, 337 (5): 315-20. 

  • Shepp DH,  Ramirez-Ronda C, Dall L, Pollard RB, Murphy RL, Kessler H,  Sherer R, Mertz G; Perez G, et.al.  A comparative trial of Zidovudine administered every four versus every twelve hours for the treatment of advanced HIV disease.  J. Acquir Immun Defic Syndr 1997; 15 (4): 283-288. 

  • Bardeguez AD, Skurnick JH, Perez G, Colon JM, Kloser P, Denny T.  Lymphocute shedding from genital tract of HIV-Infected women:  immunophenotypic and clinical correlates.  Am. J. Obstet Gynecol 1997; 176:158-65. 

  • Skurnick JH, Kennedy CA, Perez G, et al.  Behavioral and demographic risk factors for transmission of human immunodeficiency virus type 1 in heterosexual couples:  a report from the Heterosexual HIV Transmission Study.  JID 1998; 26: 855-64. 

  • Denny T, Skurnick JH, Palumbo P, Perez G, et al. CD3+CD8+ cell levels as predictors of transmission in human immunodeficiency virus-infected couples: a report from the Heterosexual HIV Transmission Study.  Int J Infect Dis 1998; 2: 186-92.. 

  • Perez G, Skurnick JH, Denny T, et al. Herpes simplex II and Mycoplasma genitalium as risk factors for heterosexual HIV transmission:  a report from the Heterosexual HIV Transmission Study.  Int J Infect Dis 1998; 3: 5-11.  

  • Bogden JD,  Kemp FW, Ham S, Li W, Bruening K.; Denny T, Oleske JM, Lloyd J, Baker H, Perez G. et.al.  Status of selected nutrients and progression of human immunodeficiency virus type 1 infection.  Am J Clin Nutr 2000; 72:809-815. 

  • Hellinger JA, Duane MK, Smith JJ, Fleishman AN, Torres RA, Schrader S, Perez G, et al. A randomized study of the safety and antiretroviral activity of hydroxyurea combined with didanosine in persons infected with human immunodeficiency virus type 1.  JID 2000; 181: 540-7. 

  • Abu-ata O, Slim J, Perez G, Smith SM. HIV therapeutics:  Past, present and future.  Adv in Pharmacol  2000; 49:1-40. 

  • Tedaldi E, Huppler-Hullisiek K, Malvestutto C, Arduino, R, Fisher E, Gaglio P, Jenny-Avital E, McGowan J, Perez G.  Prevalence and characteristics of HCV coinfection in an HIV clinical trials group.  Clin Infect Dis 2003; 36:1313-17. 

  • Perez G, MacArthur R, Walmsley S, et.al.  A multinational randomized clinical trial comparing nelfinavir and ritonavir in 775 patients (CPCRA 042/CTN 102).  HIV Clinical Trial 2004; 5(1):7-18. 

  • Smith SM, Donio MJ, Singh M, Fallon JP, Jitendrath L, Chrebeti N, Slim J, Perez G.  Prevalence of GBV virus type C in urban Americans infected with human immunodeficiency type 1.  Retrovirology 2005; 2: 38-41. 

  • Loutfy MR, Walmsley SM, Mullin CM, Perez G, et al.  CD4+ cell count increase predicts clinical benefits in patients with advanced HIV disease and persistent viremia after 1 year of combination antiretroviral therapy.  JID 2005; 192: 1407-11.  

  • MacArthur RD, Perez G, Walmsley S et al.  Comparison of prognostic importance of latest CD4 cell count and HIV RNA levels in patients with advanced HIV infection on highly active antiretroviral therapy.  HIV Clin Trials 2005; 127-35 

  • D:A:D Study Group.  Use of nucleotide reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients in the D:A:D study: a multi-cohort collaboration.  Lancet 2008; 371: 1417-26. 

  • Data Collection on Adverse Events of Anti-HIV Drugs Study Group.  Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction.  Clin Infect Dis 2008; 46: 1101-10. 

  • Strategies for Management of Antiretroviral Therapy (SMART) Study Group.  Major clinical outcomes in antiretroviral therapy (ART)-naïve participants and in those not receiving ART at baseline in the SMART study.  JID 2008; 197: 1133-44 

  • Strategies for Management of Antiretroviral Therapy (SMART) Study Group.  Inferior clinical outcomes of the CD4+ cell count-guided antiretroviral treatment interruption strategy in the SMART study: role of CD4+ cell counts and HIV RNA levels during follow-up.  JID 2008; 197: 1145-55. 

  • INSIGHT Cause of Death Writing Group. Determination of the cause of death in three multicenter international HIV clinical trials.  HIV Clin Trials 2008; 9: 177-85.  

  • BENCHMRK Study Team.  Raltegravir with optimized background therapy for resistant HIV-1 infection.  N Engl J Med 2008; 359: 334-54. 

  • BENCHMRK Study Team.  Subgroup and resistance analyses of raltegravir for resistant HIV-1 infection.  N Engl J Med 2008; 359: 355-65. 

  • SMART Study Group.  Risk for opportunistic disease and death after reinitiating antiretroviral therapy with HIV previously receiving episodic therapy: a randomized trial.  Ann Intern Med 2008; 149: 289-99. 

  • Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study Group.  HIV-induced immunodeficiency and mortality for AIDS-defining and no-AIDS-defining malignancies.  AIDS 2008; 22: 2143-53. 

  • SMART Study Group.  Viral resuppression and detection of drug resistance following interruption of a suppressing non-nucleoside reverse transcriptase based regimen.  AIDS 2008; 22: 2279-89. 

  • INSIGHT SMART Study Group.  Interruption of antiretroviral therapy is associated with increased plasma cystatin C.  AIDS 2009; 23: 71-82. 

  • Stepanyuk O, Chang TS, Dever LL, Paez SL, Smith SM, Perez G, Eng RH.  Impact of adding maraviroc to antiretroviral regimens in patients with full viral suppression but impaired CD4 recovery.  AIDS 2009; 23: 1911-13. 

  • INSIGHT Strategies for Management of Antiretroviral Therapy (SMART) Study Group.  Activation and coagulation biomarkers are independent predictors of the development of opportunistic disease in patients with HIV infection.  JID 2009; 200: 973-83. 

  • INSIGHT-ESPRIT Study Group; SILCAAT Scientific Committee.  Interleukin-2 therapy in patients with HIV infection.  N Engl J Med 2009; 361: 1548-59. 

  • D:A:D Study Group.  High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of the metabolic syndrome.  AIDS 2010; 24: 427-35. 

  • SWITCHMRK 1 and 2 investigators.  Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viremia (SWITCHMRK 1 and 2): two multicentre double-blind, randomized controlled trials.  Lancet 2010; 375: 396-407. 

  • BENCHMRK Study Teams.  Long term efficacy and safety of raltegravir combined with optimized background therapy in treatment-experienced patients with drug-resistant HIV infection: week 96 results of the BENCHMRK 1 and 2 phase III trials.  Clin Infect Dis 2010; 50: 605-12. 

  • INSIGHT STALWART Study Group.  Effects of intermittent IL-2 alone or with peri-cycle antiretroviral therapy in early HIV infection:  the STALWART study.  PLoS One 2010; 5(2): e9334. 

 

 

ABSTRACTS 1988- 2008 

  • DeFronzo, S.; Johnson, E.; Perez, G.; Slim, J.  Ceftazidime Monotherapy for Pseudomonas meningitis.  Abstract 3rd pan American Congress of Infectious Diseases, 1996. 

  • Perez, G.; Slim, J.; DeFronzo, S.; et.al.  Etiology of Community Acquired Hospitalized Pneumonias in an Urban Teaching Hospital.  Abstract 3rd Pan American Congress of Infectious Diseases, 1986. 

  • Slim, J.; Johnson, E.; Perez, G.  Comparison of Methicillin-Resistant Staphylococcus Aureus Bacteremias with Respect to Prior Antibiotic Administration.  Abstract 3rd Pan American Congress of Infectious Diseases, 1986. 

  • Slim, J.; Perez, G.; Shafi, A.; Johnson, E.  Short Course Therapy for Pneumocystis Carinii.  29th I.C.A.A.C.  Houston, TX.  June, 1989 

  • Slim, J.; Perez, G.; Shafi, A.; Johnson, E. Final Diagnosis in Patients with negative Bronchoalveor Lavage for Pneumocystis 5th International Conference on AIDS.  Montreal, Canada.  June, 1989. 

  • Slim, J.; Perez, G.; Heldge, D.; Perez, E.  Hospital Cost DRG Reimbursement for HIV Admissions 5th International Conference on AIDS.  Montreal, Canada.  June 1989.  

  • Slim, J.; Perez, G.; Forrester, C., Ronnesen, G.; Johnson, E.  Zidovudine Use in Intravenous Drug Users.  5th International Conference on AIDS.  Montreal, Canada.  June, 1989. 

  • Slim, J.; Gatio, A.; Perez, E.; Calandriello, A.; Johnson, E.; Perez, G.  Universal Precautions Warranted for Unidentified HIV-Infected Patients.  89th ASM Annual Meeting, New Orleans, LA  May 1989. 

  • Slim, J.; Gatio, A.; Perez, E.; Calandriello, A.; Johnson, E.; Incidence of HIV Infection in Unidentified Hospitalized Patients.  89th SM Annual Meeting.  New Orleans, LA.  May, 1989. 

  • Totino, E.; Perez, G.  Susceptibility of Enterobacteriacae in Clinical Isolates to Broad Spectrum Antimicrobial Agents.  91st ASM Annual Meeting.  Dallas, TX. 

  • Perez, G.; Marton, R.; Lam, Sihoi, et.al.  A randomized Prospective comparison of Twice Daily and Twice Weekly Trimethorprin-Sulfamethoxasole as Pneumocystis Prophylaxis.  VII International AIDS Conference.  Florence, Italy, June 1991. 

  • Perez, G.; DeSimone, ED.; Soroko, T.; et.al.  Correlation of Hepatitis B Serology in Discordant Couples at Risk for HIV Transmission.  VII International AIDS Conference, Florence, Italy, June 1991. 

  • Denny, T.; Crenshaw, K.; Monel, R.; Scolpino, A.; Perez, G.; et.al.  Laboratory Evaluation of HIV Discordant Heterosexual Couples:  A Report from the Heterosexual Transmission Study.  VIII International AIDS Conference.  Amsterdam, the Netherlands.  July, 1992. 

  • Perez, G.; Nahmias, A.; Denny, T.; et.al.  Correlation of Herpes II Serology in Discordant Couples at Risk for HIV Transmission;  A Report from HATS.  IX International AIDS Conference.  Berlin, Germany.  June 1993. 

  • Boghossian, J.; Perez, G.; Denny, T.; et.al.  Comparison of Syphilis Serology in Discordant and Concordant Couples with HIV Disease;  A Report from HATS.  IX International AIDS Conference.  Berlin, Germany.  June 1993. 

  • Poblete, R.; Perez, G.; DeSimone, ED.; et.al.  Comparison of Hepatitis B Serology in Couples with HIV.  IX International AIDS Conference.  Berlin, Germany.  June 1993. 

  • Eng RHK, Perez G, Paez SL, Chang TS, Smith SM.  Impact of adding maraviroc to HIV patients with undetectable plasma RNA but are non-CD4 progressors.  48th Annual ICAAC/IDSA 46th meeting.  October 2008; Washington DC. 

World Hepatitis Summitt, Bangkok Thailand April28-30, 2026 Kevin Leyden Presented our Abstract

njcri_logo.png

393 Avenida Central

Newark, NJ 07103

973-483-3444

njcri@njcri.org

  • Facebook
  • X
  • LinkedIn
  • Instagram

393 Avenida Central

Newark, NJ 07103

973-483-3444

njcri@njcri.org

Temos tantas coisas interessantes acontecendo, seja o primeiro a descobrir!

Por mais de 35 anos, o NJCRI forneceu serviços de tratamento e cuidados para HIV/AIDS a indivíduos no norte de Nova Jersey, em alinhamento com os padrões federais e estaduais de qualidade, responsabilidade e acesso equitativo.

393 Avenida Central

Newark, NJ 07103

973-483-3444

njcri@njcri.org

Encruzilhada (Centro de Acolhimento)

45 Commerce Street, Newark, NJ 07103

Horário de funcionamento do prédio: das 7h às 15h.

© Copyright by NJCRI 2025. Todos os direitos reservados.

bottom of page